Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB 239063 (SB239063) is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 43.00 | |
2 mg | In stock | $ 58.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 162.00 | |
25 mg | In stock | $ 353.00 | |
50 mg | In stock | $ 529.00 | |
100 mg | In stock | $ 767.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 71.00 |
Description | SB 239063 (SB239063) is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms. |
Targets&IC50 | p38β:44 nM, p38α:44 nM |
In vitro | SB 239063 potently inhibits IL-1 and TNF-α production in LPS-stimulated human peripheral blood monocytes with IC50 of 120 and 350 nM, respectively. [1] In oxygen-glucose-deprived hippocampal slice cultures, SB239063 strikingly reduces the levels of the pro-inflammatory cytokine IL-1beta, causes cell death after oxygen-glucose deprivation and significantly diminishes microglia activation. [2] In human corneal endothelial cell, SB 239063 inhibits TGF-β(2) and FGF-2-induced cell migration. [4] |
In vivo | In both guinea pigs and mice, SB 239063 (10 mg/kg, p.o.) reduces antigen-induced airway eosinophilia. [1] In air- and ozone-exposed C57/BL6 and MKP-1(-/-) mice, SB239063 inhibits bronchial contraction. [3] |
Synonyms | SB239063 |
Molecular Weight | 368.4 |
Formula | C20H21FN4O2 |
CAS No. | 193551-21-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.7 mg/mL (10 mM), Heating is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SB 239063 193551-21-2 Autophagy MAPK p38 MAPK inhibit SB-239063 SB239063 Inhibitor inhibitor